VB Devices

What VB Devices does

VB Devices (legal entity VASCULAR BARCELONA DEVICES, SL) is a privately held medical device company founded in 2016 in Barcelona, Spain, by vascular surgeon Dr. Enric Roche and economist/biomedical entrepreneur Federico Grego. The company designs and commercializes devices that aim to standardize and simplify vascular medicine procedures, targeting vascular surgeons, interventionalists, and phlebology specialists globally. Its three-product portfolio comprises VARIXIO, an automated microfoam preparation system for sclerotherapy of varicose veins (consisting of a Pro Mag magnetic stirrer plus consumable Pod Air and Pod Low N2 single-use capsules); CRABCLAMP+, a guidewire and catheter stabilization device for endovascular procedures capable of securing up to four guidewires; and CUTNEEDLE, a scalpel-free access needle for Seldinger procedures that remains in development.

The underlying technology combines proprietary electromechanical design (magnetic stirrer capsule docking) with purpose-engineered mechanical geometries (notched support base and bridge for wire management, step-enlarging needle for insertion). VB Devices earns revenue by selling its medical device hardware — CRABCLAMP+ through global medical device distributor networks, and VARIXIO via a dedicated varixio.com storefront alongside its distributor channel — with VARIXIO's consumable Pod capsules providing a recurring revenue stream layered on the installed base of Pro Mag stirrers. Pricing is not publicly disclosed, consistent with contact-based institutional selling to hospitals and surgical centers.

Commercial validation is evidenced through named clinician users in Spain (Rubén Rodrigues Carvajal, Hospital d'Estepona), the UK (Mark Whiteley, The Whiteley Clinic), and Singapore (Tjun Yip Tang, Gleneagles Hospital Singapore), alongside multiple non-dilutive funding awards from the European Union (Horizon 2020 grant 887677, NextGenerationEU Recovery Plan) and Spanish/regional programs (ENISA, ICEX Next, ICEX-BREXIT 2023, ACCIÓ e-Trade). One dilutive round of $226,463 from ICF Capital on 2021-12-23 has been recorded. The company is founder-controlled, privately held, and operates with a named team of approximately ten members totaling over 100 years of combined biomedical experience.

Name

VB Devices

Legal name

VASCULAR BARCELONA DEVICES, SL

Website

https://vbdevices.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

1–10 employees

Short description

VB Devices is a Barcelona-based medical device company developing VARIXIO microfoam preparation systems, CRABCLAMP+ guidewire stabilization devices, and CUTNEEDLE access needles for vascular surgeons, interventionalists, and phlebology specialists worldwide, sold through distributor networks and a dedicated VARIXIO storefront.

Ownership category

akta.pro rank

Product category

Vascular Medical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Vascular Access & Closure Devices (Sheaths, Guidewires, Closure Systems) (HLAHAFAK)

akta.pro secondary industry

Cardiac Surgery Devices (Cannulas, Clamps, Closure, Grafts) (HLAHAFAH)

Keywords

• Vascular medical devices
• Sclerotherapy equipment
• Guidewire stabilization
• Microfoam preparation
• Endovascular instruments

Headquarters

HQ city

Barcelona

HQ country

Spain

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Technology or R&D, Operations, Marketing or Sales, Others

Revenue model

1. Medical Device Sales: VB Devices generates revenue through the sale of proprietary medical devices for vascular procedures. Products include VARIXIO (microfoam preparation system with Pod capsules), CRABCLAMP+ (guidewire stabilization device), and CUTNEEDLE (access needle). Products are sold through distributor networks.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

VB Devices (legally VASCULAR BARCELONA DEVICES, SL) develops, manufactures and sells proprietary medical devices for vascular medicine procedures. Its commercial portfolio includes the VARIXIO automated microfoam preparation system for sclerotherapy treatment of varicose veins (consisting of the VARIXIO Pro Mag magnetic stirrer and VARIXIO Pod Air and Pod Low N2 single-use capsules), the CRABCLAMP+ guidewire and catheter stabilization device for endovascular procedures, and the CUTNEEDLE scalpel-free access needle (still in development) for Seldinger procedures. Products are sold primarily through medical device distributors to hospitals and vascular specialists.

Product overview

VB Devices is a medical device company offering three products for vascular medicine. VARIXIO® is the core automated microfoam preparation system for sclerotherapy, comprising the VARIXIO® Pro Mag magnetic stirrer and VARIXIO® Pod capsules (Air and Low N2 variants) for treating varicose veins, haemorrhoids, and venous malformations. CRABCLAMP®+ is a catheter and guidewire stabilization device for endovascular procedures. CUTNEEDLE® is a next-generation needle for scalpel-free access during Seldinger procedures. The product portfolio focuses on adding standardization and versatility to vascular medicine procedures.

Differentiator

Problem solved

Functional benefit

Brands

• VARIXIO: The most advanced microfoam preparation system for sclerotherapy for the treatment of varicose veins. Consists of VARIXIO Pro Mag (magnetic stirrer), VARIXIO Pod Air (sterile single-use capsules for air-based sclerosing foam), and VARIXIO Pod Low N2 (sterile single-use capsules for low-nitrogen sclerosant foam).
• CRABCLAMP+
• CUTNEEDLE

Products and services

• VARIXIO® automated microfoam preparation system Automated microfoam preparation system for sclerotherapy treatment of varicose veins, haemorrhoids and venous malformations. Consists of the VARIXIO Pro Mag magnetic stirrer and sterile single-use VARIXIO Pod Air (air-based sclerosing foam) and VARIXIO Pod Low N2 (low-nitrogen sclerosant foam) capsules. Designed for phlebology and vascular treatment specialists seeking standardized, high-quality foam at low sclerosant concentrations.
• CRABCLAMP+® guidewire and catheter stabilization device Stabilization device for endovascular procedures that holds catheters, guidewires and other elements in a fixed position. Features a support base with grooves, 3 notches with slits for guidewires from 0.014 to 0.038 inches, and a longitudinal bridge, and can secure up to 4 guidewires simultaneously. Acts as a "third hand in the O.R." for vascular surgeons and interventionalists.
• CUTNEEDLE® scalpel-free access needle Next-generation needle device for insertion-site enlargement during Seldinger procedures without requiring a scalpel, enabling precise, gradual and controlled enlargement of the insertion site and dissection of subcutaneous tissue after serving as pathway for the guidewire. Marketed as adding safety, simplicity and precision while removing the separate enlargement step.

Quantifiable outcome

• VARIXIO enables production of stable foam at low sclerosant concentrations previously not achievable
• +1 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• AngioDynamics: Markets the VenaCure line of endovenous laser and sclerotherapy products used by vascular surgeons and phlebologists. Directly comparable because it targets the same clinical segments (venous disease, sclerotherapy, endovenous ablation) with both capital equipment and consumable accessories.
• Boston Scientific: Owns Varithena (acquired via BTG), the leading polidocanol microfoam sclerotherapy product and the most direct competitor to VARIXIO. Comparable because it sells a category-defining microfoam pharmaceutical-device for treating varicose veins through procedural vascular specialists.
• Merit Medical Systems: Manufactures a wide range of interventional vascular devices including access needles, guidewires, and procedural accessories used in endovascular procedures. Directly comparable to CRABCLAMP+ and CUTNEEDLE in the interventional vascular accessory category.

Broad incumbents

• Abbott: Through Abbott Vascular, sells a broad portfolio of guidewires, sheaths, and vascular closure devices. Comparable as a broad incumbent whose vascular access and closure devices overlap with VB Devices' endovascular accessory positioning.
• Teleflex: Broad-line vascular access and interventional portfolio (including former Vascular Solutions assets) supplying sheaths, guidewires, and procedural accessories to vascular surgeons. Comparable as a larger incumbent that overlaps with CRABCLAMP+ and CUTNEEDLE across endovascular workflows.
• Becton Dickinson (BD): Global leader in vascular access (catheters, needles, guidewires) and procedural accessories used in interventional radiology and vascular surgery. Comparable as a broad-line incumbent whose vascular access portfolio overlaps CRABCLAMP+ and CUTNEEDLE.
• Medtronic: Operates one of the largest vascular and endovascular device portfolios (AAA, peripheral, venous) including closure devices and access tools. Comparable as a broad incumbent whose endovascular suite competes across the same procedural touchpoints as VB Devices.

Emerging players

• Penumbra: Specializes in mechanical thrombectomy and vascular access catheters (Indigo, Lightning). Comparable as a focused, innovation-led player targeting vascular specialists with novel procedural tools, similar in stage-and-strategy positioning to VB Devices.
• Inari Medical: Focused exclusively on venous and thromboembolic disease with the FlowTriever and ClotTriever systems used by vascular interventionalists. Comparable as a niche, KOL-driven, vascular-specialist company that scaled from procedural accessories into broader venous franchises.

Others

• BTG International (now part of Boston Scientific): Original developer and commercializer of Varithena prior to acquisition by Boston Scientific in 2019. Relevant as the historical direct competitor whose microfoam sclerotherapy franchise VARIXIO most directly challenges.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/VBDevices
• LinkedInlinkedin.com/company/vascularbarcelonadevices

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about VB Devices